Destruction Of Cancer Skin Growth Of Scalp, Neck, Hands, Feet, Or Genitals, 2.1-3.0 Cm in Pennsylvania
Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.
Top Providers in Pennsylvania
| Provider | Medicare | Services |
|---|---|---|
| Bronfenbrener, Roman MD | $160.95 | 61 |
| Thieu, Khanh M.D. | $173.34 | 18 |
| Nguyen, Loanna FNP | $122.47 | 16 |
| Stoner, John D.O. | $153.91 | 13 |
| Thieu, Minh M.D. | $177.28 | 13 |
| Perlis, Clifford M.D. | $163.83 | 11 |
Pennsylvania Pricing in Context
In Pennsylvania, CPT code 17273 (Destruction Of Cancer Skin Growth Of Scalp, Neck, Hands, Feet, Or Genitals, 2.1-3.0 Cm) carries an average Medicare payment of $143.94 — 2% above the national benchmark of $140.73. 200 providers across the state submitted claims for this procedure in 2023, performing 579 total services. Individual payments in PA ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.
The average billed charge in Pennsylvania is $396.05, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because Pennsylvania sits above the national Medicare average, commercial rates in the state may also run higher than the US median.
Using RAND 2024 commercial-to-Medicare ratios for Skin/Integumentary Surgery procedures, the estimated commercial insurance price in Pennsylvania lands near $409.37, with self-pay cash prices typically around $248.47. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.
Frequently Asked Questions
How much does Destruction Of Cancer Skin Growth Of Scalp, Neck, Hands, Feet, Or Genitals, 2.1-3.0 Cm cost in Pennsylvania?
The average Medicare payment for Destruction Of Cancer Skin Growth Of Scalp, Neck, Hands, Feet, Or Genitals, 2.1-3.0 Cm in Pennsylvania is $143.94, which is 2% above the national average of $140.73. Providers in PA typically bill $396.05 for this procedure.
What does Destruction Of Cancer Skin Growth Of Scalp, Neck, Hands, Feet, Or Genitals, 2.1-3.0 Cm cost with insurance in Pennsylvania?
With commercial insurance in Pennsylvania, Destruction Of Cancer Skin Growth Of Scalp, Neck, Hands, Feet, Or Genitals, 2.1-3.0 Cm costs an estimated $409.37. Without insurance, the estimated cash price is $248.47. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.
How many providers perform Destruction Of Cancer Skin Growth Of Scalp, Neck, Hands, Feet, Or Genitals, 2.1-3.0 Cm in Pennsylvania?
200 providers in Pennsylvania billed Medicare for Destruction Of Cancer Skin Growth Of Scalp, Neck, Hands, Feet, Or Genitals, 2.1-3.0 Cm in 2023, performing 579 total services. Medicare payments ranged from N/A to N/A depending on the provider.
Is Destruction Of Cancer Skin Growth Of Scalp, Neck, Hands, Feet, Or Genitals, 2.1-3.0 Cm cheaper in Pennsylvania than the national average?
No — Destruction Of Cancer Skin Growth Of Scalp, Neck, Hands, Feet, Or Genitals, 2.1-3.0 Cm costs 2% above the national average in Pennsylvania. The state average Medicare payment is $143.94 compared to $140.73 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.
Related Guides
Related Data Sources
Data from CMS Medicare Physician & Other Practitioners (2023).
Read our methodology — how this data is sourced, computed, and verified.